PPARγ Agonist Pioglitazone Reverses Memory Impairment and Biochemical Changes in a Mouse Model of Type 2 Diabetes Mellitus

Aims: Pioglitazone, known as a peroxisome proliferator‐activated receptor γ (PPARγ) agonist, is used to treat type 2 diabetes mellitus (T2DM). T2DM has been associated with reduced performance on numerous domains of cognitive function. Here, we investigated the effects of pioglitazone on memory impa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Jiang, Li‐Ying, Tang, Su‐Su, Wang, Xiao‐Yun, Liu, Li‐Ping, Long, Yan, Hu, Mei, Liao, Ming‐Xing, Ding, Qi‐Long, Hu, Wei, Li, Jia‐Chang, Hong, Hao
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493499/
https://ncbi.nlm.nih.gov/pubmed/22620268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2012.00341.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados